AI diagnosis from medical images: Industries
Industries
The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
Used by- Diagnostic laboratories and imaging centres Faster reading and triage Imaging centres and radiology departments use most products; 76.5% of US AI device authorisations to 2025 were in radiology [6].
- Primary care clinics and doctors' practices Screening without a specialist IDx-DR was tested on 900 patients with diabetes at 10 primary care sites [3, 9].
- Medical-device companies (OEMs) Software as a medical device Each product is regulated as a medical device; the FDA had authorised more than 1,600 by 2026 [4].
- AI and digital platforms Research and products Technology firms such as Google developed some of the best-known systems [2].
- Device regulators and notified bodies New review rules Regulators had to decide how to authorise software that makes a diagnosis on its own, starting with IDx-DR in 2018 [3].
as of 2026-11-11
Sources
- Deep Learning for Detection of Diabetic Eye Disease (29 November 2016) Google Research blog (L. Peng and V. Gulshan), 2016
- FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems Healthcare Innovation (HCI Innovation Group), reproducing the FDA news release of 11 April 2018, 2018
- Artificial Intelligence-Enabled Medical Devices US Food and Drug Administration, 2026
- Radiology dominates thirty years of FDA AI device approvals AuntMinnie (Will Morton, 16 July 2026), reporting a study by P. Golshani and others in Cureus (doi 10.7759/cureus.112583), which could not be opened, 2026
- De Novo classification request for IDx-DR (decision summary, DEN180001) US Food and Drug Administration, 2018